GH Research PLC (GHRS)
9.62
-1.33
(-12.15%)
USD |
NASDAQ |
Nov 21, 16:00
9.55
-0.07
(-0.73%)
Pre-Market: 20:00
GH Research Enterprise Value: 350.47M for Nov. 21, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 21, 2024 | 350.47M |
| November 20, 2024 | 419.67M |
| November 19, 2024 | 349.95M |
| November 18, 2024 | 342.67M |
| November 15, 2024 | 322.90M |
| November 14, 2024 | 316.66M |
| November 13, 2024 | 330.70M |
| November 12, 2024 | 326.02M |
| November 11, 2024 | 320.30M |
| November 08, 2024 | 297.92M |
| November 07, 2024 | 298.45M |
| November 06, 2024 | 303.65M |
| November 05, 2024 | 267.75M |
| November 04, 2024 | 266.19M |
| November 01, 2024 | 273.99M |
| October 31, 2024 | 271.39M |
| October 30, 2024 | 283.36M |
| October 29, 2024 | 271.39M |
| October 28, 2024 | 269.31M |
| October 25, 2024 | 247.98M |
| October 24, 2024 | 242.78M |
| October 23, 2024 | 240.69M |
| October 22, 2024 | 281.80M |
| October 21, 2024 | 281.80M |
| October 18, 2024 | 282.32M |
| Date | Value |
|---|---|
| October 17, 2024 | 266.19M |
| October 16, 2024 | 252.66M |
| October 15, 2024 | 219.36M |
| October 14, 2024 | 227.17M |
| October 11, 2024 | 207.40M |
| October 10, 2024 | 229.25M |
| October 09, 2024 | 192.31M |
| October 08, 2024 | 185.02M |
| October 07, 2024 | 177.74M |
| October 04, 2024 | 187.63M |
| October 03, 2024 | 189.71M |
| October 02, 2024 | 178.78M |
| October 01, 2024 | 183.46M |
| September 30, 2024 | 198.03M |
| September 27, 2024 | 206.64M |
| September 26, 2024 | 212.88M |
| September 25, 2024 | 227.97M |
| September 24, 2024 | 229.53M |
| September 23, 2024 | 212.36M |
| September 20, 2024 | 232.65M |
| September 19, 2024 | 254.50M |
| September 18, 2024 | 264.39M |
| September 17, 2024 | 270.11M |
| September 16, 2024 | 276.88M |
| September 13, 2024 | 280.52M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
112.35M
Minimum
Dec 18 2023
1.171B
Maximum
Nov 09 2021
441.73M
Average
389.42M
Median
Mar 21 2024
Enterprise Value Benchmarks
| Amarin Corp PLC | -89.82M |
| Jazz Pharmaceuticals PLC | 11.06B |
| Prothena Corp PLC | 257.74M |
| Iterum Therapeutics PLC | 31.18M |
| Mural Oncology PLC | -118.01M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -12.11M |
| Total Expenses (Quarterly) | 12.62M |
| EPS Diluted (Quarterly) | -0.23 |
| Earnings Yield | -8.21% |